Federal Supply Schedule 36F79720D0073
Award Date
2/1/20
Last Date to Order
7/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Asegua Therapeutics LLC
Ultimate Awardee
Gilead Sciences Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) has awarded Gilead Sciences Inc., a prominent biopharmaceutical company, multiple federal contract Indefinite Delivery Vehicles (IDVs) to supply critical pharmaceutical products to VA healthcare programs. The primary IDV is a $29.16 million single-award Blanket Purchase Agreement (BPA) with the VA National Acquisition Center, spanning from November 2022 through October 2025. This BPA enables VA medical facilities nationwide to efficiently procure...
The U.S. Department of Veterans Affairs National Acquisition Center has awarded a single-award Blanket Purchase Agreement (BPA) to Gilead Sciences Inc., doing business as Gilead, for the procurement of the pharmaceutical products Letairis, Yescarta, and Tecartus. The BPA has a ceiling value of $29,160,000.00 and a period of performance through October 31, 2025. Gilead, a prominent biopharmaceutical company, is the sole-source manufacturer of these specialized medications, which are critical...
The U.S. Department of Veterans Affairs (VA) has awarded a multiple award Federal Supply Schedule (FSS-61-IB) contract to Sobi, Inc., a foreign-owned, for-profit pharmaceutical company, with a ceiling value of $78 million through July 2025. This contract enables the VA to procure pharmaceuticals and drug products, such as TEGSEDI and ORFADIN, to support healthcare services for veterans. Additionally, the VA National Acquisition Center has awarded a single-award Blanket Purchase Agreement (BPA)...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Celltrion USA Inc., provides for the delivery of pharmaceuticals, medical devices, and related products to support the government's COVID-19 response efforts. The $250,000 contract, which runs through April 2026, is under the GSA Pharmaceuticals and Drugs (FSS-61-IB) schedule. As a prime contractor, Celltrion has fulfilled delivery orders ranging from $1,080 to $12 million on a firm-fixed price...
This Federal Supply Schedule contract awarded by the Department of Veterans Affairs to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, has a total ceiling value of $4,927,972,430. The contract covers a wide range of drugs, pharmaceuticals, and hematology-related products under FSC code 65 IB. Key task orders under this IDV include a $396,999,400 firm-fixed-price delivery order for Tamiflu capsules, a $21,999,907 firm-fixed-price delivery order for the antiviral drug...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to G1 Therapeutics, Inc. for the provision of pharmaceutical and drug products. The contract has a ceiling value of $2,250,000.00 and a period of performance through July 14, 2026. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and allows for the delivery of a broad range of drug and hematology-related products to the VA and its related healthcare...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract, V797D70240, to Helsinn Therapeutics (U.S.), Inc. (doing business as Helsinn Therapeutics US Inc.), a for-profit manufacturer of pharmaceutical products. The FSS contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, has a ceiling value of $3,281,482.80 and a period of performance through February 2025. Under this FSS contract, Helsinn Therapeutics has received several delivery order...
The Department of Veterans Affairs awarded a multiple-award Federal Supply Schedule contract to Viela Bio, Inc. against the Pharmaceuticals and Drugs schedule for an estimated $12.98 million. This IDV establishes supply of pharmaceutical products to various VA medical centers nationwide through 2022. A single-award Blanket Purchase Agreement against the same FSS schedule was also awarded to Viela Bio for an estimated $4.35 million. This BPA facilitates streamlined delivery of the neuromyelitis...
The Department of Veterans Affairs (VA) has awarded a multiple-award Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs to AbbVie US LLC, a subsidiary of the global biopharmaceutical company AbbVie Inc. The contract has an ultimate completion date of December 31, 2025 and a $8,590,452,220 ceiling value. Under this FSS contract, AbbVie US LLC has received numerous delivery orders from the VA's Veterans Integrated Service Networks (VISNs) for the provision of critical...